PubMed Health⌕ Search

PubMed · 6811488

Immunostimulation by vitamin C.

Abstract

A review of the literature shows that vitamin C undoubtedly has a positive effect on some mechanisms of the natural resistance against infections as well as on the immune response. It is generally accepted that vitamin C increases the chemotaxis of granulocytes and of macrophages. There is also ample evidence that vitamin C increases the phagocytic activity of granulocytes as well as of macrophages. As to the effect of vitamin C on the immune response, the available data allow the conclusion that vitamin C is necessary for the induction of delayed hypersensitivity, i.e. cellular immunity. Its effect on the antibody production appears, however, to be minimal or none. In our previous in vivo studies we obtained the results which were consistent with the conclusion that high doses of vitamin C increase the efficiency of immunization with a human cell culture rabies vaccine in guinea-pigs. The purpose of this study was to establish whether relatively low doses (10 mg/kg body weight) of vitamin C have a similar effect as megadoses (100 mg/kg body weight). We observed that the efficiency of immunization with the human diploid cell culture rabies vaccine (Mérieux/Lyon) was better in the group of guinea-pigs treated with the vaccine plus vitamin C (10 mg/kg body weight) than in the group treated with the vaccine alone. The difference in the number of survivors in both groups of animals was statistically not significant, but considering the factor of repetition (a similar result in repeated experiments) we nevertheless conclude that vitamin C acts in the doses used as an immunopotentiator.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Banic. 1982. Immunostimulation by vitamin C.. https://pubmed.ncbi.nlm.nih.gov/6811488/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response.

Single-stranded RNA oligonucleotides containing an immunostimulatory motif (immunostimulatory RNA [isRNA]) are potent inducers of interferon-alpha via the Toll-like receptor 7. We investigated the effect of isRNA on the development of an immune response. We show that isRNA activates dendritic cells and induces production of Th1-type cytokines both in vitro and in vivo. Cytokine production led to bystander activation of T and B cells. We further demonstrate that isRNA triggers the generation of antigen-specific cytotoxic T cells and of an IgG2a-biased antibody response to antigen in a sequence-dependent manner. In summary, we provide evidence for the first time that isRNA oligonucleotides can simultaneously activate the innate and adaptive arms of the immune system.

Adjuvants, Immunologic↗

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.

Dendritic-tumor heterokaryons generated by electrofusion are highly immunogenic. In animal studies, a single vaccination was therapeutic for tumors established in the lung, skin, and brain. However, effective therapy required a third signal which could be provided by exogenous IL-12 or the agonistic anti-OX-40R monoclonal antibody (mAb). In this study, we investigated the mechanism and mode of actions of these two seemingly distinct adjuvants. In immunotherapy of the MCA205 sarcoma, administration of the neutralizing anti-IL-12 mAb nearly completely blocked the adjuvant effect of IL-12, but had minimal inhibitory effects on anti-OX-40R mAb. By contrast, in vivo administration of the antagonistic anti-OX-40L mAb inhibited the adjuvant effects of both IL-12 and anti-OX-40R mAb. Thus, a common pathway of endogenous OX-40 interaction is critical for the development of a therapeutic immune response. Analysis of the third signal mechanism revealed that in the absence of an adjuvant, vaccination with fusion hybrids led to IL-10 production without eliciting IFN-gamma secreting cells. The addition of IL-12 to vaccination suppressed IL-10 production and initiated sensitization of specific IFN-gamma secreting cells, resulting in a type 1-like antitumor immunity. These findings underscore the significance of the third signal in the design of dendritic cell-based cancer vaccines.

Adjuvants, Immunologic↗